文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

脓毒症患者胆固醇与脂蛋白变化趋势与急性呼吸窘迫综合征发生率及死亡相关

TRENDS IN CHOLESTEROL AND LIPOPROTEINS ARE ASSOCIATED WITH ACUTE RESPIRATORY DISTRESS SYNDROME INCIDENCE AND DEATH AMONG SEPSIS PATIENTS.
PubMed 文献 · Shock · 2023-12-28
一句话结论脓毒症合并ARDS患者的总胆固醇变化趋势与非ARDS患者不同,且ARDS死亡者总胆固醇、LDL-C和载脂蛋白A-I水平更低。

本研究重新分析了前瞻性脓毒症研究数据,纳入214例脓毒症患者(48例合并ARDS,166例未合并ARDS),比较入组时(脓毒症最初24小时)及48-72小时后胆固醇和脂蛋白水平的变化。结果显示,入组时两组胆固醇和脂蛋白水平相似,但48-72小时后,ARDS组总胆固醇中位变化值(-4,IQR -23.5, 6.5,n=35)与非ARDS组(0,IQR -10.0, 17.5,P=0.04,n=106)有显著差异。按ARDS生存状态比较,死亡者(n=14)入组时总胆固醇(75.5,IQR 68.4, 93.5)、LDL-C(27,IQR 19.5-34.5)和载脂蛋白A-I(87.6,IQR 76.45-103.64)均低于存活者(n=33);48-72小时死亡者低密度脂蛋白胆固醇(9.0,IQR 4.3, 18.0,n=10)、LDL-C(17.0,IQR 5.0, 29.0,n=9)和总胆固醇(59.0,45.3, 81.5,n=10)也显著低于存活者。作者认为,未来需研究脓毒症ARDS患者胆固醇代谢失调的生物学机制及与潜在治疗的联系。

要点

  • 脓毒症合并ARDS患者48-72小时总胆固醇中位变化值为-4(IQR -23.5, 6.5,n=35),非ARDS患者为0(IQR -10.0, 17.5,P=0.04,n=106),两组变化趋势显著不同。
  • ARDS死亡者入组时总胆固醇中位75.5(IQR 68.4, 93.5)低于存活者113.0(IQR 84.0, 126.8,P=0.022)。
  • ARDS死亡者入组时LDL-C中位27(IQR 19.5-34.5)低于存活者43(IQR 27-67,P=0.013,n=33)。
  • ARDS死亡者48-72小时总胆固醇中位59.0(45.3, 81.5,n=10)低于存活者105.0(IQR 91.0, 115.0,P=0.003)。
  • ARDS死亡者48-72小时LDL-C中位17.0(IQR 5.0, 29.0,n=9)低于存活者42.0(IQR 27.0-58.0,P=0.019)。

适用人群与场景

  • 脓毒症患者,来自前瞻性脓毒症研究数据的再分析,纳入214例,其中48例合并ARDS,166例未合并ARDS。
  • 比较入组时(脓毒症最初24小时)及48-72小时后的胆固醇和脂蛋白水平。

研究设计与关键结果

  • 研究类型:对前瞻性脓毒症研究数据的再分析;样本量214例脓毒症患者(48例ARDS,166例非ARDS)。
  • 入组时脓毒症ARDS与非ARDS患者胆固醇和脂蛋白水平相似。
  • 48-72小时总胆固醇中位变化值(48/72小时-入组时):ARDS组-4(IQR -23.5, 6.5,n=35)vs 非ARDS组0(IQR -10.0, 17.5,P=0.04,n=106)。
  • ARDS死亡者(n=14)入组时总胆固醇中位75.5(IQR 68.4, 93.5)vs ARDS存活者(n=33)113.0(IQR 84.0, 126.8,P=0.022)。
  • ARDS死亡者(n=14)入组时LDL-C中位27(IQR 19.5-34.5)vs ARDS存活者(n=33)43(IQR 27-67,P=0.013)。
  • ARDS死亡者(n=14)入组时载脂蛋白A-I中位87.6(IQR 76.45-103.64)vs ARDS存活者(n=33)130.0(IQR 73.25-165.47,P=0.047)。
  • 48-72小时ARDS死亡者低密度脂蛋白胆固醇中位9.0(IQR 4.3, 18.0,n=10)vs ARDS存活者(n=25)20.0(IQR 12.0-39.0,P=0.014)。
  • 48-72小时ARDS死亡者LDL-C中位17.0(IQR 5.0, 29.0,n=9)vs ARDS存活者(n=25)42.0(IQR 27.0-58.0,P=0.019)。

证据类型、等级与局限

  • 证据类型:对前瞻性脓毒症研究数据的再分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来需研究脓毒症ARDS患者胆固醇代谢失调的生物学机制及与潜在治疗的联系。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objective: Compare changes in cholesterol and lipoprotein levels occurring in septic patients with and without acute respiratory distress syndrome (ARDS) and by survivorship. Methods: We reanalyzed data from prospective sepsis studies. Cholesterol and lipoprotein levels were analyzed using univariate testing to detect changes between septic patients with or without ARDS, and among ARDS survivors compared with nonsurvivors at enrollment (first 24 h of sepsis) and 48 to 72 h later. Results: 214 patients with sepsis were included of whom 48 had ARDS and 166 did not have ARDS. Cholesterol and lipoproteins among septic ARDS versus non-ARDS showed similar enrollment levels. However, 48 to 72 h after enrollment, change in median total cholesterol (48/72 h - enrollment) was significantly different between septic ARDS (-4, interquartile range [IQR] -23.5, 6.5, n = 35) and non-ARDS (0, -10.0, 17.5, P = 0.04; n = 106). When compared by ARDS survivorship, ARDS nonsurvivors (n = 14) had lower median total cholesterol levels (75.5, IQR 68.4, 93.5) compared with ARDS survivors (113.0, IQR 84.0, 126.8, P = 0.022), and lower median enrollment low-density lipoprotein cholesterol (LDL-C) levels (27, IQR 19.5-34.5) compared with ARDS survivors (43, IQR 27-67, P = 0.013; n = 33). Apolipoprotein A-I levels were also significantly lower in ARDS nonsurvivors (n = 14) (87.6, IQR 76.45-103.64) compared with ARDS survivors (130.0, IQR 73.25-165.47, P = 0.047; n = 33). At 48 to 72 h, for ARDS nonsurvivors, median levels of low-density lipoprotein cholesterol (9.0, IQR 4.3, 18.0; n = 10), LDL-C (17.0, IQR 5.0, 29.0; n = 9), and total cholesterol (59.0, 45.3, 81.5; n = 10) were significantly lower compared with ARDS survivors' (n = 25) levels of low-density lipoprotein cholesterol (20.0, IQR 12.0-39.0, P = 0.014), LDL-C (42.0, IQR 27.0-58.0, P = 0.019), and total cholesterol (105.0, IQR 91.0, 115.0, P = 0.003). Conclusions: Change in total cholesterol was different in septic ARDS versus non-ARDS. Total cholesterol, LDL-C, and apolipoprotein A-I levels were lower in ARDS nonsurvivors compared with survivors. Future studies of dysregulated cholesterol metabolism in septic ARDS patients are needed to understand biology and links to potential therapies.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Black LP, Hopson C, Barker G, et al. TRENDS IN CHOLESTEROL AND LIPOPROTEINS ARE ASSOCIATED WITH ACUTE RESPIRATORY DISTRESS SYNDROME INCIDENCE AND DEATH AMONG SEPSIS PATIENTS. Shock. 2023. PMID: 38407817. doi:10.1097/SHK.0000000000002295

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。